MedPath

A Randomized Controlled Trial on Effect of Tai Chi versus aerobic exercise on Blood Pressure in Prehypertension Patients

Not Applicable
Conditions
Prehypertension
Registration Number
ITMCTR1900002448
Lead Sponsor
Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged 18 to 65 years;
2. With a systolic blood pressure in the range of 120 mm Hg to 139 mm Hg and/or a diastolic blood pressure in the range of 80 mm Hg to 89 mm Hg;
3. No western medicine or traditional Chinese medicine, acupuncture and moxibustion were used to control blood pressure (or the treatment was discontinued for 2 weeks);
4. Willing to be randomized to Tai Chi group or aerobic exercise group;
5. Ability to complete written questionnaires and operate electronic equipment independently;
6. Able to give informed consent.

Exclusion Criteria

1. Secondary hypertension;
2. Pregnant and lactating women;
3. Non-dominant arm circumference > 50 cm;
4. Body mass index larger than 40.0 kg/m2;
5. Take benzodiazepines, antipsychotics or oral glucocorticoids (allowed to taken fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram and escitalopram stably within 3 months);
6. Diagnosed with diabetes mellitus and coronary heart disease;
7. Chronic kidney disease with eGFR < 60 mL/min;
8. With known autonomic neuropathy (such as Shy-Drager syndrome, orthostatic hypotension, white coat hypertension);
9. Male's alcohol intake was more than 25 g/day or 140 g/week or female's alcohol intake was more than 15 g/day or 80 g/week;
10. Has played Tai Chi more than once a month in the past six months;
11. Vigorous sports activities more than three times a week;
12. Severe musculoskeletal problems lead to the inability to practise Tai Chi;
13. Current participants in clinical trials of other drugs or external therapies.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
systolic blood pressure in office blood pressure;
Secondary Outcome Measures
NameTimeMethod
Four items of blood lipid;urinary microalbumin;Number of patients with office blood pressure changed to normal blood pressure (SBP<120 mmHg/DBP<80 mmHg);24-hour mean blood pressure;SCORE Score of European Clinical Practice;rapid blood glucose;urinary albumin;glycosylated hemoglobin;diastolic blood pressure in office blood pressure;24-hour ambulatory blood pressure variability;urine beta-2 microglobulin;Number of people with SBP 135-144 mmHg or DBP 85-89 mmHg in Home BP;Number of admissions due to acute cardio-cerebrovascular attacks and new atrial fibrillation events;6 months ± 7 days;Number of patients with office blood pressure changed to SBP140-159 mmHg/DBP90-99 mmHg;
© Copyright 2025. All Rights Reserved by MedPath